• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number PAJR051002B
Device Problem Activation Failure (3270)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/06/2019
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing records for the device verified the lot met all pre-release specifications.
 
Event Description
The following information was reported to gore: on (b)(6) 2019 a patient was undergoing treatment of a right distal popliteal lesion with a gore® viabahn® endoprosthesis with propaten bioactive surface.The lesion was predilated by means of angioplasty.The device was advanced to the target location and positioned.The deployment knob was unscrewed and the deployment line was pulled.The endoprosthesis started to deploy a few millimeters, however resistance was felt, so pulling on the line was stopped.This device was removed from the patient through the sheath.
 
Manufacturer Narrative
H.6.Results code 2: 213: the engineering evaluation stated the following: the entire device was returned.There was approximately 31.5cm of deployment line between the hub and deployment knob.Approximately 2.5cm of the distal shaft, upon which the endoprosthesis is mounted, was exposed at the transition.Approximately 1.5cm of the endoprosthesis was expanded.The remainder of the endoprosthesis was constrained by the inner braided constraining line.The endoprosthesis was longitudinally compressed towards the tip end of the device with the expanded portion of the endoprosthesis covering the distal tip.The endoprosthesis appeared to be damaged with outwardly flared struts throughout the expanded portion.Additionally, the wire stent appeared to be delaminating from the graft.The rest of the device appeared unremarkable.Deployment was able to be continued with traction on the deployment line at the endoprosthesis.Engineering evaluation conclusion is inconclusive as it relates to the event description.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9107005
MDR Text Key160411939
Report Number2017233-2019-00884
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 10/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/15/2022
Device Catalogue NumberPAJR051002B
Device Lot Number20619440
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age63 YR
-
-